Thu, Mar 28, 2024
A A A
Welcome Guest
Free Trial RSS pod
Get FREE trial access to our award winning publications
Alternative Market Briefing

The impact of COVID-19 on activist investing

Friday, May 01, 2020

Bailey McCann, Opalesque New York:

Activist investing could drop to levels not seen since 2014 in the immediate aftermath of the coronavirus outbreak, according to new research from Activist Insight.

Data in the report shows that there was a significant uptick in proxy statements in 2009, 2017, and 2019 following periods of falling stock prices. The increase in proxy filings during those periods suggests that activists may be gearing up for a series of fights over the next few years. Businesses appear to be positioning themselves more defensively ahead of any action. Companies have responded to this year's volatility by implementing so-called "poison pills," including as many as 40 by April 21. Firms are also changing their bylaws in response to the current environment.

Social distancing may end up saving some companies from proxy filings. The report notes that holding annual meetings in person is going to be difficult until there is a vaccine or treatment for COVID-19. Without an annual meeting, it becomes that much harder to launch a proxy fight. Shareholders may also be less focused on proxy issues overall if they are dealing with virus response and may be more inclined to side with management if management says it is dealing with special circumstances as a result of the crisis.

For activists to make it through the crisis, the report suggests that they'll have to bring especially high conviction cases to be seen and heard. Or, they will have to be......................

To view our full article Click here

Previous Opalesque Exclusives                                  
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. KKR raises $6.4bn for the largest pan-Asia infrastructure fund[more]

    Laxman Pai, Opalesque Asia: The New York-based global investment firm KKR has raised a record $6.4bn for its second Asia-focused infrastructure fund, underlining investors' continued appetite for private markets. According to a media release from the alternative assets manager, the figure top

  2. Bucking the trend, top hedge fund makes plans for a second SPAC[more]

    From Institutional Investor: SPACs aren't dead. At least not to the folks at Cormorant Asset Management. The life sciences firm, whose hedge fund topped its peers in 2023, is confident it will match the success of its first blank-check company. Last week, the life sciences and biopharma speciali

  3. Benefit Street Partners closes fifth fund on $4.7 billion[more]

    Bailey McCann, Opalesque New York: Benefit Street Partners has closed its fifth flagship direct lending vehicle, BSP Debt Fund V, with $4.7 billion of investable capital across the strategy. Benefit Street invests primarily in privately originated, floating rate, senior secured loans. The fun

  4. 4 hedge fund themes that are working in 2024[more]

    From The Street: A poor earnings report from Tesla (TSLA) has not hurt the indexes on Thursday. The decline in Tesla stock, which is losing its position in the Magnificent Seven pantheon, is more than offset by strong earnings from IBM (IBM) and ServiceNow (NOW) . In addition, the much higher-t

  5. Opalesque Exclusive: A global macro fund eyes opportunities in bonds[more]

    Bailey McCann, Opalesque New York for New Managers: Munich-based ThirdYear Capital rebounded in 2023, following a tough year for global macro. The firm's flagship ART Global Macro strategy finished the year up 1